TrialJournal of gastroenterology2017

Four-year maintenance treatment with adalimumab in Japanese patients with moderately to severely active ulcerative colitis.

Yasuo Suzuki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.